“Drug marketers now realize that the growing trend toward self-administration for chronic conditions such as MS and arthritis presents unique challenges for combination products. Success in these markets is highly dependent on understanding patient needs and incorporating delivery technologies that are patient-friendly and can improve compliance.”
“To meet the challenge of pediatric therapeutics, unique formulations and improved delivery methods will be essential. We are forecasting rapid growth in this sector, with specialized pediatric delivery products representing more than one-third of all pediatric prescriptions by the end of the decade.”
“The combination of improved particle properties and more efficient inhaler designs is creating new opportunities for dry powder inhalation and expanding the range of active compounds that can be effectively delivered via the lung. We believe dry powder inhalation will become a major factor in the delivery of a number of emerging therapeutics.”
